Ronald Oude‐Elferink

849 total citations
15 papers, 540 citations indexed

About

Ronald Oude‐Elferink is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Ronald Oude‐Elferink has authored 15 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Ronald Oude‐Elferink's work include Drug Transport and Resistance Mechanisms (5 papers), Liver Diseases and Immunity (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Ronald Oude‐Elferink is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Liver Diseases and Immunity (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Ronald Oude‐Elferink collaborates with scholars based in Netherlands, United States and Finland. Ronald Oude‐Elferink's co-authors include Ulrich Beuers, Simon Hohenester, Jung‐Chin Chang, Andreas E. Kremer, Thomas Pusl, Peter L. M. Jansen, Vassilis Triantis, Nora Bijl, Eiríkur Saeland and Nobuyo Maeda and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Ronald Oude‐Elferink

15 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Oude‐Elferink Netherlands 10 215 197 190 180 140 15 540
Jūratė Kondrackienė Lithuania 10 342 1.6× 395 2.0× 81 0.4× 286 1.6× 193 1.4× 13 818
Janneke M. Stapelbroek Netherlands 9 330 1.5× 378 1.9× 154 0.8× 140 0.8× 184 1.3× 22 781
Yasuaki Takeyama Japan 13 201 0.9× 203 1.0× 80 0.4× 219 1.2× 268 1.9× 67 617
Maw‐Chang Sheen Taiwan 9 65 0.3× 110 0.6× 127 0.7× 118 0.7× 192 1.4× 20 448
Atsuhiro Morita Japan 10 126 0.6× 114 0.6× 117 0.6× 258 1.4× 265 1.9× 13 600
Yvonne Bury United Kingdom 9 78 0.4× 61 0.3× 100 0.5× 111 0.6× 120 0.9× 18 438
Phillips Mj Canada 19 404 1.9× 241 1.2× 128 0.7× 280 1.6× 165 1.2× 38 853
De Kai QIU China 11 126 0.6× 72 0.4× 88 0.5× 216 1.2× 371 2.6× 14 548
Chunfang Gao China 11 315 1.5× 196 1.0× 106 0.6× 41 0.2× 84 0.6× 19 469
Susan Kennedy United States 9 81 0.4× 55 0.3× 247 1.3× 69 0.4× 59 0.4× 10 659

Countries citing papers authored by Ronald Oude‐Elferink

Since Specialization
Citations

This map shows the geographic impact of Ronald Oude‐Elferink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Oude‐Elferink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Oude‐Elferink more than expected).

Fields of papers citing papers by Ronald Oude‐Elferink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Oude‐Elferink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Oude‐Elferink. The network helps show where Ronald Oude‐Elferink may publish in the future.

Co-authorship network of co-authors of Ronald Oude‐Elferink

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Oude‐Elferink. A scholar is included among the top collaborators of Ronald Oude‐Elferink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Oude‐Elferink. Ronald Oude‐Elferink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tolenaars, Dagmar, et al.. (2022). The IgG4-related cholangitis autoantigen laminin 511-E8 stabilizes the biliary bicarbonate umbrella in human cholangiocytes. Journal of Hepatology. 77. S603–S604. 1 indexed citations
2.
Bosma, Piter J., et al.. (2020). Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects. International Journal of Molecular Sciences. 22(1). 273–273. 16 indexed citations
3.
Lívero, Francislaine Aparecida dos Reis, Caroline Machado Kopruszinski, Cibele C. Cardoso, et al.. (2015). Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats. Chemico-Biological Interactions. 228. 46–56. 17 indexed citations
4.
Ovadia, Caroline, Shadi Abu‐Hayyeh, Peter Dixon, et al.. (2014). P379 BIOCHEMICAL MARKERS FOR INTRAHEPATIC CHOLESTASIS OF PREGNANCY AND PRURITUS GRAVIDARUM IN WOMEN WITH GESTATIONAL PRURITUS. Journal of Hepatology. 60(1). S194–S194. 2 indexed citations
5.
Chang, Jung‐Chin & Ronald Oude‐Elferink. (2014). Role of the bicarbonate-responsive soluble adenylyl cyclase in pH sensing and metabolic regulation. Frontiers in Physiology. 5. 42–42. 42 indexed citations
6.
Triantis, Vassilis, Eiríkur Saeland, Nora Bijl, Ronald Oude‐Elferink, & Peter L. M. Jansen. (2010). Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19–mediated down‐regulation of cytochrome P450 7A1†. Hepatology. 52(2). 656–666. 42 indexed citations
7.
Bronckers, A.L.J.J., Ineke D.C. Jansen, Juan F. Medina, et al.. (2009). Localization and function of the anion exchanger Ae2 in developing teeth and orofacial bone in rodents. Journal of Experimental Zoology Part B Molecular and Developmental Evolution. 312B(4). 375–387. 39 indexed citations
8.
Hohenester, Simon, Ronald Oude‐Elferink, & Ulrich Beuers. (2009). Primary biliary cirrhosis. Seminars in Immunopathology. 31(3). 283–307. 127 indexed citations
9.
Kremer, Andreas E., Ulrich Beuers, Ronald Oude‐Elferink, & Thomas Pusl. (2008). Pathogenesis and Treatment of Pruritus in Cholestasis. Drugs. 68(15). 2163–2182. 80 indexed citations
10.
Markusic, David M., Alexander Kanitz, Ronald Oude‐Elferink, & Jurgen Seppen. (2007). Preferential Gene Transfer of Lentiviral Vectors to Liver-Derived Cells, Using a Hepatitis B Peptide Displayed on GP64. Human Gene Therapy. 18(7). 673–679. 11 indexed citations
11.
Klett, Eric L., Kangmo Lu, Astrid Kosters, et al.. (2004). A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Medicine. 2(1). 5–5. 113 indexed citations
12.
Til, Niek P. van, David M. Markusic, Cindy Kunne, et al.. (2004). Kupffer Cells and Not Liver Sinusoidal Endothelial Cells Prevent Lentiviral Transduction of Hepatocytes. Molecular Therapy. 11(1). 26–34. 41 indexed citations
13.
Strautnieks, Sandra, Alberto Lopes, James A. Underhill, et al.. (2002). Critical residues in the multidrug resistance 3 protein gene associated with adult onset cholangiopathy and intrahepatic cholestasis of pregnancy.. Hepatology. 36(4). 6 indexed citations
14.
Bakker, Conny, G. N. J. Tytgat, Ronald Oude‐Elferink, et al.. (1996). Reduced bilirubin UDP-glucuronosyltransferase expression in Gilbert syndrome is caused by a sequence abnormality in the promoter region. The Netherlands Journal of Medicine. 48(1). A13–A13. 1 indexed citations
15.
Ottenhoff, R., K. P. Dingemans, G. N. J. Tytgat, et al.. (1995). Influence of dietary cholate and ursodeoxycholate on liver pathology in mdr2 knockout mice. The Netherlands Journal of Medicine. 47(2). A7–A8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jūratė Kondrackienė Breakdown of academic impact, for papers by Janneke M. Stapelbroek Breakdown of academic impact, for papers by Yasuaki Takeyama Breakdown of academic impact, for papers by Maw‐Chang Sheen Breakdown of academic impact, for papers by Atsuhiro Morita Breakdown of academic impact, for papers by Yvonne Bury Breakdown of academic impact, for papers by Phillips Mj Breakdown of academic impact, for papers by De Kai QIU Breakdown of academic impact, for papers by Chunfang Gao Breakdown of academic impact, for papers by Susan Kennedy
Rankless by CCL
2026